Johnson and Johnson’s vaccine is 66% effective against moderate to severe COVID-19 01/29/2021 Health News, Johnson and Johnson's single-shot coronavirus vaccine is 85% effective in preventing severe COVID-19 and 66%...
Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata 01/05/2019 Medications, January 3, 2019 -- Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase...
Moderate carbohydrate intake may be best for health 08/17/2018 Health News, Eating carbohydrates in moderation seems to be optimal for health and longevity, suggests new research...